Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antagonist versus PPOS ovarian stimulation in POSEIDON group 2 IVF/ICSI patients
ChiCTR2200056027Phase 4Recruiting
- Sponsor
- The First Hospital of Lanzhou University
- Start
- Feb 2022
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of progesterone, follitropin alfa, triptorelin and human chorionic gonadotropin in infertility (2 arms), sponsored by The First Hospital of Lanzhou University. Primary endpoint: Cumulative clinical pregnancy rate. Started Feb 2022; status: recruiting.
02
Drugs
progesteronefollitropin alfatriptorelinhuman chorionic gonadotropin
03
Conditions
infertility
Beyond the preview
Go deeper on ChiCTR2200056027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056027.